Lupin launches first generic of Pred Forte in the US
Lupin has commenced shipment with a 180-day CGT exclusivity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
How warehouse automation is creating impact on medical distribution
The COVID-19 pandemic brought into view how fragile global supply chains are and the need for further agility and robustness.This…
Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease
The trial will also evaluate Key Secondary Endpoints including Mean change in haemoglobin, the proportion of patients requiring…
19th International Conference of Drug Regulatory Authorities commences in India
ICDRA is being hosted for the first time in India, bringing together regulatory authorities, policymakers, and health officials…
Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory…
Intas Pharmaceuticals acquired exclusive commercialisation rights to DMB-3115 through a license agreement in 2021
S1P receptor modulators face uncertain future in Crohn’s disease amid trial setbacks
GlobalData’s Ulcerative Colitis Market Forecast expects Zeposia to have sales of $374.2 million worldwide in 2031, compared to…
Rajeev Juneja takes charge as senior VP of PHDCCI
PHD Chamber of Commerce and Industry announces new leadership for its President, Senior VP, an VP roles
UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
Capsules of controversy: India’s growing appetite for dietary supplements
The author highlights regulatory challenges and the growing risks in India's dietary supplements industry
University of Central Lancashire partners with Brinton Healthcare UK to explore nanoparticle…
The collaboration will focus on developing innovative skincare therapies using topical nanocarriers